Clinical trial
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
NCT02673047 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- August 31, 2016
- Enrollment
- 474 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.